[Response to DDAVP in von Willebrand disease type II C].
D000941:Antigens / Q000032:analysis; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005169:Factor VIII / Q000032:analysis / Q000276:immunology; D006801:Humans; D014914:Whole Blood Coagulation Time; D014842:von Willebrand Diseases / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000032:analysis
D000941:Antigens; D014841:von Willebrand Factor; D001127:Arginine Vasopressin; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin
Respuesta al DDAVP en la enfermedad de von Willebrand tipo II C.